katero
Jul 01, 2026

The GLP-1 Price Trick Nobody Talks About and the Company That Refuses to Play It

blue-haven-rx
Blue Haven RX

Sponsored content. Us Weekly receives compensation for this article as well as for purchases made when you click on a link and buy something below.

You’ve seen the ads: “$99/month for semaglutide!” “$149 to start tirzepatide!” Sounds reasonable, so you sign up, do everything right, and your dose goes up. Suddenly, your bill does too.

That’s not a bug. It’s the business model. Most GLP-1 programs charge more at higher doses, which means the advertised price only applies to the lowest possible starting dose. By the time you reach a real therapeutic level, you could be paying significantly more than what pulled you in.

Blue Haven RX doesn’t do that – the number on the bill never jumps as you titrate up.

One price. Every dose. No exceptions.

Compounded tirzepatide through Blue Haven RX is $179 per month¹ — not $179 to start, but $179 at 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and at the full 15 mg dose. Similarly, compounded semaglutide is $149/month at every dose. No membership fees, no separate consultation fees, no hidden fees, and free shipping included. The number on your bill in month one is the same number in month six.

Blue Haven RX runs on what they call Demand-Based Growth, a business model that flips the usual playbook. Keep the price genuinely low, attract a large volume of subscribers, and because the volume is there, the price can stay low. Demand protects the price, and the price feeds the demand.

Because the model works through volume rather than margins, Blue Haven RX doesn’t need to burn money on celebrity endorsements, influencer campaigns, or the AI-generated testimonials you’ve probably scrolled past.

The team has a shorter name for the philosophy behind it: Don’t Be Greedy.

The reinvestment that patients actually feel.

Other posts